Title : Vandetanib improves anti-tumor effects of L19mTNFalpha in xenograft models of esophageal cancer.

Pub. Date : 2011 Feb 1

PMID : 21106730






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To overcome tumor resistance, L19mTNFalpha scFv was combined with vandetanib, a tyrosine kinase inhibitor of VEGF receptor, epidermal growth factor receptor, and RET signaling. vandetanib vascular endothelial growth factor A Homo sapiens